Anti-LYPD8 antibodies are used in the immunodetection of the protein LY6/PLAUR domain containing 8. In humans, the canonical protein has a reported length of 237 amino acid residues and a mass of 25.3 kDa. Its subcellular localization is in the cell membrane and is secreted. It is reported to be expressed in the large intestine. It is a member of the CNF-like-inhibitor protein family. Post-translational modifications have been described, including O-glycosylation, N-glycosylation and protein cleavage. Synonyms for this target antigen include ly6/PLAUR domain-containing protein 8 and phospholipase inhibitor. LYPD8 gene orthologs have been reported in the mouse, rat, bovine and chimpanzee species. Flow Cytometry is the most common application for the LYPD8 antibodies listed below. Immunocytochemistry and Immunohistochemistry are also common applications.